Securities and Exchange Commission Uses in Return of Confidential Information Clause

Return of Confidential Information from License Agreement

This LICENSE AGREEMENT (this "Agreement") is made and entered into as of this 3rd day of May, 2010 ("Effective Date") by and between Peregrine Pharmaceuticals, Inc., organized under the laws of Delaware, having its principal place of business at 14282 Franklin Avenue, Tustin, CA 92780 ("Licensor"), and Stason Pharmaceuticals, Inc., organized under the laws of California, having its principal place of business at 11 Morgan, Irvine, California 92618-4327 ("Licensee"). Licensor and Licensee may each be referred to herein individually as a "Party" and collectively as the "Parties."

Return of Confidential Information. Upon any termination of this Agreement, each Party shall promptly return to the other Party, or destroy at the other Party's option, all Confidential Information received from the other Party, including all reproductions and copies thereof in any medium, except one copy of which may be retained for archival purposes.